StormHarvester is a smart drainage company. We make smart sewers a reality by using AI to detect blockages and improve wastewater network performance. Our core competency is bringing together our machine learning approach with hyperlocal rainfall forecasting. We have created the ability to accurately forecast asset conditions 6 hours into the future, and take pre-emptive actions. We can also pre-emptively attenuate stormwater and harvest rainwater in building projects using one ‘smart’ tank, as well as controlling open-water levels in ponds, lakes and reservoirs. We aim to help our customers reduce costs, make operations efficient, optimise infrastructure and minimise environmental impact.
Stora
Stora is the operating platform built for modern self storage businesses. Trusted by more than 25% of the UK’s self storage facilities and used by over 1,000 sites across 15 countries, Stora is now bringing its automation-focused platform to the United States. Built for scale, Stora replaces legacy systems with one reliable platform that connects the core parts of a storage operation. Online bookings, automated billing, access control, pricing, and live performance data are all managed in one place, giving operators clear oversight across every site. Automation sits at the centre of the platform. Routine tasks that traditionally require manual work — from billing and customer communications to pricing adjustments and reporting — run automatically, allowing teams to focus on growing the business rather than managing day-to-day administration. Stora also protects and expands revenue through built-in pricing tools and automated increases, ensuring rates stay aligned with demand without inconsistent manual decisions across locations. Designed for both single sites and growing portfolios, Stora integrates easily with existing systems and evolves as businesses scale. Operators use Stora to modernise their facilities, improve operational performance, and run their storage business with greater control and efficiency.
Sepha Ltd.
Sepha offers a range of non-destructive leak test & CCIT solutions, deblistering machines, and laboratory-scale blister packing machines for the pharmaceutical industry. These systems support the manufacture of blister packs, medical devices, and healthcare products. Our solutions are designed to help customers improve quality assurance, reduce manufacturing costs, and meet the stringent regulatory requirements of the industry. All Sepha products comply with ASTM standards, align with USP 1207, support 21 CFR Part 11, and integrate with Manufacturing Execution Systems (MES).Join us on booth W-16064 for live demonstrations:High-Sensitive CCIT & Leak Test SolutionsMulti-QThe Multi-Q offers ultra-sensitive Container Closure Integrity (CCI) testing based on vacuum decay (ASTM F2338-09) and pressure decay. This non-destructive and deterministic system detects micro leaks as small as 1μm (container and content dependent). Designed for flexibility, it supports a variety of parenteral containers, including glass or plastic vials, ampoules, pre-filled syringes, bottles, and BFS (Blow Fill Seal). The system also integrates pressure decay testing for products like toxic liquids, oil-based solutions, lyo/powders, glucose/protein, or other materials that can’t be tested using vacuum decay. Compact and bench-top, the Multi-Q is suitable for both lab work and in-process batch testingLearn more about the Sepha Multi-Q VisionScan 3DThe VisionScan 3D employs a 3D measurement process to assess blister pack integrity, identifying defects as small as 5μm without the need for tooling. It works with both matte & gloss foil types. This system allows different text patterns to be tested in a single method, making it ideal for production lines that feature multiple language variations. Its large test area can simultaneously inspect several packs, enhancing efficiency in operations with frequent product changes. Using vacuum deflection (ASTM standard test method F3169-16), VisionScan 3D provides a non-destructive, deterministic alternative to blue dye testing. Learn more about the Sepha VisionScan 3D PakScanPakScan is a non-destructive seal integrity tester for pouches, sachets, and flexible packaging containing dry powder or solid materials. It can detect gross holes, leaks, and weak seals down to 10μm (depending on pack & material) and can test up to 10 packs simultaneously in just 30 seconds. The system delivers objective, deterministic results, shown as pass/fail for each individual packet on the result screen. PakScan’s software complies with FDA 21 CFR Part 11, allowing manufacturers to store and export data for audits while protecting reports from being modified or deleted. Learn more about the PakScan Small-Scale Blister PackagingEZ Blister+Meeting the surge in demand for micro-batch blister packaging with 21 CFR Part 11 compliance, the EZ Blister+ integrates compact packaging efficiency with advanced traceability and data management. From R&D to commercial production, it provides the creation of electronic signatures, batch reports, audit trails and other electronic documentation. The Structured Query Language (SQL) database system at the core of the EZ Blister+ powers a host of applications on the machine, from recipe creation and management to reporting, as well as facilitating integration with factory networks and Management Execution Systems (MES). Learn more about the EZ Blister+Sepha LinksDiscover our deblistering solutionsMore about Sepha
SciLeads
Find Your Ideal Biotech, Pharma, and Academic Prospects. Containing the world’s most accurate and comprehensive database of research scientists, SciLeads enables sales and marketing teams to identify, engage and qualify their ideal prospects. Use tradeshow, funding, and publication intelligence to find leads and create engaging messages that convert them to customers.
Northern Ireland – Materials Handling
15 companies will be exhibiting on the Northern Ireland stand at ConExpo 2026. Northern Ireland is the home of mobile bulk materials handling equipment with world-class solutions in aggregate processing. Companies from the region are renowned for their innovative approach to providing a diverse range of cost-effective solutions tailored to individual customer needs, with an extensive product range, from OEMs to supply chain companies, catering for the full range of requirements of the bulk materials processing industry. Visit us in Central Hall, Stand C22233, to meet the companies, who are keen to find new USA partners, and find out more about Northern Ireland’s world-class capabilities.
MediNect Ophtho
MediNect Ophtho is a specialist preclinical research division of MediNect Bioservices Ltd., focused on accelerating therapeutic development for retinal and ocular diseases. The team combines deep expertise in in vivo, ex vivo, and advanced in vitro models, including diabetic macular edema, retinal degeneration, and subretinal fibrosis. With a strong scientific foundation—over 80% of staff holding PhDs—and leadership experienced in advancing drugs to clinical trials, MediNect Ophtho delivers high-quality, translational data to support decision-making from early discovery through to IND-enabling studies. By integrating academic insight with CRO delivery, the group provides flexible, bespoke study design tailored to biotech and pharmaceutical partners worldwide.
Invest Northern Ireland
As the regional business development agency for Northern Ireland, Invest Northern Ireland’s role is to grow the local economy. We do this by helping new and existing businesses to compete internationally, and by attracting new investment to Northern Ireland. Northern Ireland is a prime location for Life and Health Sciences businesses, thanks to its unique combination of talented people, world-class research, and an ecosystem that benefits from a strong collaborative approach between industry, academia, and clinicians in the commercialization of innovative research. The region is home to more than 250 Life and Health Sciences companies who can support all aspects of your drug development cycle, from discovery through preclinical and clinical research, to commercial manufacturing and lifecycle management. Northern Ireland continues to play a key role in solving global healthcare challenges through innovation, with businesses of all sizes focused on advancing pharmaceuticals, diagnostics, precision medicine, connected health, and medical devices. Specialisms: Northern Ireland provides an opportunity to capitalize on cutting-edge technology and to partner with local expert companies to develop, test, validate, and commercialize advanced therapeutics, biomarker assays and precision diagnostics, accelerating precision medicine applications. Queen’s University Belfast and Ulster University, Northern Ireland’s two major universities, provide globally competitive research expertise, along with 17 life sciences-related Centers of Excellence with over 1,000 researchers. To find out more about the Northern Ireland companies at BIO visit: https://www.investni.com/trade-mission/export-events/bio-international-convention-2023 | As the regional business development agency for Northern Ireland, Invest Northern Ireland’s role is to grow the local economy. We do this by helping new and existing businesses to compete internationally, and by attracting new investment to Northern Ireland. Northern Ireland is a prime location for Life and Health Sciences businesses, thanks to its unique combination of talented people, world-class research, and an ecosystem that benefits from a strong collaborative approach between industry, academia, and clinicians in the commercialization of innovative research. Following the UK’s exit from the European Union (EU), Northern Ireland continues to have access to Great Britain (GB) and EU markets for goods. This means that Northern Ireland is a gateway for the sale of goods to two of the world’s largest markets and the only place where businesses can operate free from customs declarations, rules of origin certificates and non-tariff barriers on the sale of goods to both GB and the EU. The region is home to more than 250 Life and Health Sciences companies who can support all aspects of your drug development cycle, from discovery through preclinical and clinical research, to commercial manufacturing and lifecycle management. Northern Ireland continues to play a key role in solving global healthcare challenges through innovation, with businesses of all sizes focused on advancing pharmaceuticals, diagnostics, precision medicine, connected health, and medical devices. Specialisms: Northern Ireland provides an opportunity to capitalize on cutting-edge technology and to partner with local expert companies to develop, test, validate, and commercialize advanced therapeutics, biomarker assays and precision diagnostics, accelerating precision medicine applications. Queen’s University Belfast and Ulster University, Northern Ireland’s two major universities, provide globally competitive research expertise, along with 17 life sciences-related Centers of Excellence with over 1,000 researchers. To find out more about Northern Ireland’s Life and Health Sciences sector, visit: https://www.investni.com/life-and-health-sciences | Invest Northern Ireland
InBroadcast
Digitally published by Le Sommet Limited, InBroadcast is the global broadcast industry’s monthly, high-quality Magazine and associated content hub for Audio, A/V,Film, Mobile, Satellite, Television and Video professionals. Our website hosts a news service for relevant sector companies. Updated daily, a concise digest of the leading news and product launches is emailed out once a week to our managed subscriber list. | InBroadcast is the global broadcast industry’s monthly, high-quality Magazine and associated content hub for Audio, Film, Mobile, Satellite, Television and Video professionals.The InBroadcast website hosts a news service for relevant broadcast sector companies. Updated daily, a concise digest of the leading news and product launches is emailed out once a week to our managed subscriber list.The Magazine includes news, exclusive feature articles, case studies, product launches, plus event previews and reviews from all the top broadcast industry shows from around the world.
Global Health Connector
Global Health Connector helps to build a truly connected and collaborative global movement that’s driving health transformations – across themes, sectors, regions and cultures. We bring people together to accelerate health transformation through innovation, CollaborAction, and shared learning. We connect the dots, transform health, and deliver global expertise with tangible results. 78 Countries | 90+ Ecosystems | 200+ Gatherings a Year | 17K Ecosystem Participants
DisplayNote Technologies
DisplayNote is the smarter, simpler way to share content in meeting spaces or classrooms. We cut out the setup delays, cable hunting, and platform conflicts that slow things down. With wireless screen sharing that works across every major device and OS, DisplayNote keeps rooms flexible and users productive. No heavy ecosystem lock-in, no costly proprietary hardware just fast, reliable collaboration that IT can deploy and manage at scale. DisplayNote is owned by the Volaris Group part of the Canadian Constellation Software Group – listed on the Toronto Stock Exchange.